These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 18667655)

  • 21. [Conflicts of interest--an evidence-based approach].
    Slørdal L; Eggen AE; Rygnestad T
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
    [No Abstract]   [Full Text] [Related]  

  • 22. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 23. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 24. Extent and impact of industry sponsorship conflicts of interest in dermatology research.
    Perlis CS; Harwood M; Perlis RH
    J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential for bias in reporting of industry-sponsored clinical trials.
    Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
    Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.
    Liss H
    Isr Med Assoc J; 2006 Jul; 8(7):451-4. PubMed ID: 16889157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Industry sponsorship and selection of comparators in randomized clinical trials.
    Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
    Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 32. Who is buying bioethics research?
    Sharp RR; Scott AL; Landy DC; Kicklighter LA
    Am J Bioeth; 2008 Aug; 8(8):54-8; discussion W1-2. PubMed ID: 18802867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between research sponsorship and study outcome in plastic surgery literature.
    Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB
    Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do disclosure policies fail? Let us count the ways.
    de Melo-Martín I; Intemann K
    FASEB J; 2009 Jun; 23(6):1638-42. PubMed ID: 19176877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buying research.
    Lemmens PH
    Addiction; 1997 Sep; 92(9):1077-9. PubMed ID: 9374003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In the dark: drug companies should be forced to publish all the results of clinical trials.
    Chalmers I
    New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
    [No Abstract]   [Full Text] [Related]  

  • 37. Researchers raise concerns about secrecy in company-sponsored clinical trials.
    Mangan KS
    Chron High Educ; 2006 Apr; 52(31):A29. PubMed ID: 16789295
    [No Abstract]   [Full Text] [Related]  

  • 38. Conducting industry-partnered trials in orthopaedic surgery.
    Bhandari M; Jönsson A; Bühren V
    Injury; 2006 Apr; 37(4):361-6. PubMed ID: 16473356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflict of interest in the debate over calcium-channel antagonists.
    Stelfox HT; Chua G; O'Rourke K; Detsky AS
    N Engl J Med; 1998 Jan; 338(2):101-6. PubMed ID: 9420342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.